Altered myocardial force generation in end‐stage human heart failure. (15th January 2015)

• Record Type: Journal Article
• Authors: Papp, Zoltán; van der Velden, Jolanda; Borbély, Attila; Édes, István; Stienen, Ger J.M.
• Is Part Of: ESC heart failure. Volume 1:Number 2(2014:Dec.)
• Page Start: 160
• Page End: 165
• Publication Date: 2015-01-15
• Subjects: Human heart failure -- Cardiomyocyte -- Myofilament -- Actin‐myosin cross‐bridge cycle; Heart failure -- Periodicals; 616.129005
• DOI: 10.1002/ehf2.12020
• Languages: English
• ISSNs: 2055-5822

Abstract

Abstract: Aims: This study aimed to elucidate the molecular background of increased Ca 2+ sensitivity of force production in cardiomyocytes of end‐stage human heart failure. Methods and results: Ca 2+ ‐activated isometric force and the cross‐bridge specific rate of force redevelopment ( k tr ) were determined in Triton‐skinned myocytes from end‐stage failing and non‐failing donor hearts. Measurements (control: pH 7.2, 0 mM inorganic phosphate (Pi )) were performed under test conditions that probed either the Ca 2+ ‐regulatory function of the thin filaments (pH 6.5), the kinetics of the actin‐myosin cross‐bridge cycle (10 mM Pi ), or both (pH 6.5, 10 mM Pi ). The control maximal Ca 2+ ‐activated force ( F o ) and k trmax did not differ between failing and non‐failing myocytes. At submaximal [Ca 2+ ], however, both force and k tr were higher in failing than in donor myocytes. The difference in the Ca 2+ sensitivities of force production was preserved when the thin filament regulatory function was perturbed by acidosis (pH 6.5) but was abolished by cross‐bridge modulation (i.e. by Pi ) both at pH 7.2 and at pH 6.5. Pi induced a larger reduction in force but a smaller increase in k tr in the failing myocytes than in the non‐failing myocytes at submaximal [Ca 2+ ]. Conclusion: The enhanced Pi sensitivity of the actin‐myosin interaction suggests that the Pi release step of the actin‐myosin cross‐bridge cycle is modified during end‐stage human heart failure. This might be of functional importance when Pi accumulates (e.g. during cardiac ischaemia). Moreover, this alteration can influence cardiac energetics and the clinical efficacy of sarcomere targeted agents in human heart failure.